LABU ETF holdings (NYSE) - Page 4 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

SRPT Sarepta Therapeutics Inc 3.7 M 175.1 K 0.7%

CPRX Catalyst Pharmaceuticals Inc. 3.7 M 129.9 K 0.7%

BCRX BIOCRYST PHARMACEUTICALS INC 3.5 M 381.3 K 0.7%

DYN Dyne Therapeutics Inc. 3.5 M 196.9 K 0.7%

KOD Kodiak Sciences Inc 3.3 M 77.0 K 0.6%

RXRX RECURSION PHARMACEUTICALS INC 3.3 M 958.6 K 0.6%

GRAL GRAIL Inc 3.2 M 59.7 K 0.6%

RCUS Arcus Biosciences Inc. 3.2 M 123.9 K 0.6%

AGIO Agios Pharmaceuticals Inc 3.1 M 110.6 K 0.6%

DNLI Denali Therapeutics Inc 3.0 M 162.2 K 0.6%

ORKA Oruka Therapeutics Inc 3.0 M 43.6 K 0.6%

DNTH Dianthus Therapeutics Inc 3.0 M 33.6 K 0.6%

NTLA Intellia Therapeutics Inc 2.9 M 215.0 K 0.6%

ERAS Erasca Inc 2.9 M 271.2 K 0.6%

ADMA ADMA BIOLOGICS INC 2.9 M 281.7 K 0.6%

SNDX Syndax Pharmaceuticals Inc. 2.9 M 134.2 K 0.6%

ARDX Ardelyx Inc 2.8 M 439.0 K 0.5%

IDYA IDEAYA Biosciences Inc. 2.7 M 93.3 K 0.5%

MLYS Mineralys Therapeutics Inc. 2.7 M 101.6 K 0.5%

NRIX Nurix Therapeutics Inc. 2.7 M 160.9 K 0.5%

1
2
3
4
5
6
7
8